Financial statements

AbbVie Inc.

ABBV

The tables show figures AbbVie Inc. filed with the SEC, in the currency it filed in (USD). A † marks totals or quarters calculated from filed lines. Nothing here is a forecast. By fiscal year · By quarter · What moved

Latest annual figures

AbbVie Inc.: annual revenue and profit

AbbVie Inc. reported annual revenue of $61.2bn (USD) for the fiscal year ending 31 Dec 2025.

AbbVie Inc. reported annual net income of $4.2bn (USD) for the fiscal year ending 31 Dec 2025.

These are annual figures. The company report's headline twelve-month figures use an available twelve-month window from the filings and are missing when none can be calculated.

Read the ABBV company report · Browse ABBV filings on SEC EDGAR

By fiscal year

Fiscal year	Over the period	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
What it earned
RevenueWhat it sold, before any costs	+139%	$61.2bn	$56.3bn	$54.3bn	$58.1bn	$56.2bn	$45.8bn	$33.3bn	$32.8bn	$28.2bn	$25.6bn
Selling & administrative costsSpent on running the business and selling	+139%	$14.0bn	$14.8bn	$12.9bn	$15.3bn	$12.3bn	$11.3bn	$6.9bn	$7.4bn	$6.3bn	$5.9bn
Restructuring chargesOne-off costs of closing or reorganising		—	—	—	—	—	—	$219.0m	$59.0m	$86.0m	$52.0m
Operating profitProfit from the business itself	+61%	$15.1bn	$9.1bn	$12.8bn	$18.1bn	$17.9bn	$11.4bn	$13.0bn	$6.4bn	$9.6bn	$9.4bn
InterestPaid to lenders	+176%	$2.9bn	$2.8bn	$2.2bn	$2.2bn	$2.4bn	$2.5bn	$1.8bn	$1.3bn	$1.1bn	$1.0bn
TaxPaid in tax	+22%	$2.4bn	-$570.0m	$1.4bn	$1.6bn	$1.4bn	-$1.2bn	$544.0m	-$490.0m	$2.4bn	$1.9bn
Net incomeWhat was left after everything	-29%	$4.2bn	$4.3bn	$4.9bn	$11.8bn	$11.5bn	$4.6bn	$7.9bn	$5.7bn	$5.3bn	$6.0bn
Diluted EPSThat profit, per share	-35%	$2.36	$2.39	$2.72	$6.63	$6.45	$2.72	$5.28	$3.66	$3.30	$3.63
What it owns and owes
Cash & equivalentsCash it can spend today	+3%	$5.2bn	$5.5bn	$12.8bn	$9.2bn	$9.7bn	$8.4bn	$39.9bn	$7.3bn	$9.3bn	$5.1bn
InventoryGoods not yet sold	+243%	$5.0bn	$4.2bn	$4.1bn	$3.6bn	$3.1bn	$3.3bn	$1.8bn	$1.6bn	$1.6bn	$1.4bn
Current assetsWhat it owns that turns to cash within a year	+80%	$29.1bn	$25.6bn	$33.0bn	$28.5bn	$27.9bn	$24.2bn	$49.5bn	$16.9bn	$21.2bn	$16.2bn
Total assetsEverything it owns	+103%	$134.0bn	$135.2bn	$134.7bn	$138.8bn	$146.5bn	$150.6bn	$89.1bn	$59.4bn	$70.8bn	$66.1bn
Current liabilitiesWhat it owes within a year	+343%	$43.3bn	$38.7bn	$37.8bn	$29.5bn	$35.2bn	$28.7bn	$15.6bn	$17.2bn	$16.6bn	$9.8bn
Short-term debtBorrowing due within a year	+563%	$2.5bn	$0	$0	$1.0m	$14.0m	$34.0m	$0	$3.7bn	$400.0m	$377.0m
Long-term debtBorrowing due later	+77%	$64.5bn	$66.8bn	$59.2bn	$63.1bn	$76.0bn	$84.9bn	$67.2bn	$35.0bn	$31.0bn	$36.4bn
Total debtBoth kinds of borrowing together	+82%	$67.0bn^†	$66.8bn^†	$59.2bn^†	$63.1bn^†	$76.0bn^†	$85.0bn^†	$67.2bn^†	$38.7bn^†	$31.4bn^†	$36.8bn^†
Shareholders’ equityWhat would be left for owners if it paid off everything	-171%	-$3.3bn	$3.3bn	$10.4bn	$17.3bn	$15.4bn	$13.1bn	-$8.2bn	-$8.4bn	$5.1bn	$4.6bn
Where the cash went
Cash from operationsCash the business itself brought in	+91%	$19.0bn	$18.8bn	$22.8bn	$24.9bn	$22.8bn	$17.6bn	$13.3bn	$13.4bn	$10.0bn	—
Cash from investingCash spent on or raised from investments		-$6.6bn	-$20.8bn	-$2.0bn	-$623.0m	-$2.3bn	-$37.6bn	$596.0m	-$1.0bn	-$274.0m	—
Cash from financingCash raised from or returned to lenders and owners		-$12.7bn	-$5.2bn	-$17.2bn	-$24.8bn	-$19.0bn	-$11.5bn	$18.7bn	-$14.4bn	-$5.5bn	-$3.9bn
Spending on property & equipmentSpent on property and equipment	+153%	$1.2bn	$974.0m	$777.0m	$695.0m	$787.0m	$798.0m	$552.0m	$638.0m	$529.0m	$479.0m
Debt raisedBorrowed during the period	-66%	$4.0bn	$17.0bn	—	$2.0bn	$1.0bn	$3.0bn	$31.5bn	$6.0bn	$0	$11.6bn
AcquisitionsSpent buying other businesses	-92%	$204.0m	$17.5bn	$0	$255.0m	$525.0m	$38.3bn	$0	$0	$0	$2.5bn

† Worked out by us, not filed on its own. Total debt combines filed long-term debt with current debt when reported separately.

By quarter

Quarter ending	Over the period	30 Jun 2026	31 Mar 2026	31 Dec 2025	30 Sept 2025	30 Jun 2025	31 Mar 2025	31 Dec 2024	30 Sept 2024	30 Jun 2024	31 Mar 2024	31 Dec 2023	30 Sept 2023
What it earned
RevenueWhat it sold, before any costs	+22%	$17.0bn	$15.0bn	$16.6bn	$15.8bn	$15.4bn	$13.3bn	$15.1bn	$14.5bn	$14.5bn	$12.3bn	$14.3bn	$13.9bn
Gross profitWhat was left after the cost of making it		—	—	$12.1bn	—	—	—	$10.7bn	—	—	—	$8.6bn	—
Selling & administrative costsSpent on running the business and selling	+8%	$3.6bn	$3.6bn	$3.9bn^†	$3.6bn	$3.3bn	$3.3bn	$3.9bn^†	$4.2bn	$3.4bn	$3.3bn	$3.2bn^†	$3.4bn
Operating profitProfit from the business itself	+182%	$6.4bn	$4.0bn	$4.5bn^†	$1.9bn	$4.9bn	$3.7bn	-$1.5bn^†	$3.8bn	$4.0bn	$2.8bn	$3.2bn^†	$2.3bn
InterestPaid to lenders	+34%	$746.0m	$717.0m	$714.0m^†	$739.0m	$740.0m	$700.0m	$702.0m^†	$720.0m	$726.0m	$660.0m	$564.0m^†	$555.0m
TaxPaid in tax	+285%	$662.0m	$342.0m	$853.0m^†	$526.0m	$613.0m	$372.0m	-$2.2bn^†	$520.0m	$773.0m	$383.0m	$388.0m^†	$172.0m
Net incomeWhat was left after everything	+103%	$3.6bn	$695.0m	$1.8bn	$186.0m	$938.0m	$1.3bn	-$22.0m	$1.6bn	$1.4bn	$1.4bn	$822.0m	$1.8bn
Diluted EPSThat profit, per share	+103%	$2.03	$0.39	$1.02	$0.10	$0.52	$0.72	$-0.02	$0.88	$0.77	$0.77	$0.46	$1.00
What it owns and owes
Cash & equivalentsCash it can spend today	-51%	$6.6bn	$9.4bn	$5.2bn	$5.6bn	$6.5bn	$5.2bn	$5.5bn	$7.3bn	$13.1bn	$18.1bn	$12.8bn	$13.3bn
InventoryGoods not yet sold	+29%	$5.1bn	$5.0bn	$5.0bn	$4.9bn	$5.0bn	$4.5bn	$4.2bn	$4.5bn	$4.2bn	$4.2bn	$4.1bn	$4.0bn
Current assetsWhat it owns that turns to cash within a year	+1%	$33.7bn	$33.5bn	$29.1bn	$28.5bn	$29.3bn	$27.7bn	$25.6bn	$27.8bn	$33.8bn	$38.9bn	$33.0bn	$33.2bn
Total assetsEverything it owns	-1%	$135.1bn	$136.5bn	$134.0bn	$133.9bn	$137.2bn	$136.2bn	$135.2bn	$143.4bn	$141.9bn	$148.9bn	$134.7bn	$136.2bn
Current liabilitiesWhat it owes within a year	+20%	$41.6bn	$42.1bn	$43.3bn	$39.4bn	$39.8bn	$36.4bn	$38.7bn	$43.1bn	$41.9bn	$41.5bn	$37.8bn	$34.8bn
Short-term debtBorrowing due within a year	-100%	$0	$0	$2.5bn	$3.8bn	$5.6bn	$1.6bn	$0	—	—	$3.0m	$0	$2.0m
Long-term debtBorrowing due later	+12%	$62.5bn	$64.5bn	$64.5bn	$63.0bn	$63.0bn	$64.5bn	$66.8bn	$58.5bn	$58.0bn	$63.8bn	$59.2bn	$55.6bn
Total debtBoth kinds of borrowing together	+12%	$62.5bn^†	$64.5bn^†	$67.0bn^†	$66.8bn^†	$68.5bn^†	$66.1bn^†	$66.8bn^†	$58.5bn^†	$58.0bn^†	$63.8bn^†	$59.2bn^†	$55.6bn^†
Shareholders’ equityWhat would be left for owners if it paid off everything	-149%	-$5.9bn	-$6.7bn	-$3.3bn	-$2.6bn	-$183.0m	$1.4bn	$3.3bn	$6.0bn	$6.8bn	$8.0bn	$10.4bn	$12.1bn
Where the cash went
Cash from operationsCash the business itself brought in	-55%	$3.4bn^†	$3.8bn	$5.2bn^†	$7.0bn^†	$5.2bn^†	$1.6bn	$7.0bn^†	$5.4bn^†	$2.3bn^†	$4.0bn	$4.8bn^†	$7.6bn^†
Cash from investingCash spent on or raised from investments		-$1.2bn^†	-$574.0m	-$1.5bn^†	-$3.3bn^†	-$1.2bn^†	-$735.0m	-$1.9bn^†	-$8.3bn^†	-$1.1bn^†	-$9.6bn	-$800.0m^†	-$369.0m^†
Cash from financingCash raised from or returned to lenders and owners		-$5.1bn^†	$919.0m	-$4.2bn^†	-$4.6bn^†	-$2.7bn^†	-$1.3bn	-$6.9bn^†	-$3.1bn^†	-$6.1bn^†	$10.8bn	-$4.4bn^†	-$2.7bn^†
Spending on property & equipmentSpent on property and equipment	+47%	$322.0m^†	$265.0m	$329.0m^†	$381.0m^†	$269.0m^†	$235.0m	$291.0m^†	$249.0m^†	$241.0m^†	$193.0m	$205.0m^†	$219.0m^†
Debt raisedBorrowed during the period		$0^†	$8.0bn	$0^†	$0^†	$0^†	$4.0bn	$2.0bn^†	$0^†	$0^†	$15.0bn	—	$0^†
AcquisitionsSpent buying other businesses		$0^†	$0	$0^†	$0^†	$0^†	$204.0m	$0^†	$8.3bn^†	$0^†	$9.2bn	—	$0

† Worked out by us, not filed on its own. Total debt combines filed long-term debt with current debt when reported separately. For other marked lines, the company reports from the start of its year, so the quarter is one running total less the one before it.

What moved

The largest movements in the tables above, with what else moved alongside them. Anything filed near a movement is listed as having been filed near it — that is a date, not a cause.

Shareholders’ equity fell in each of the last 3 fiscal years

By the numbersOver the same period: total debt rose 0.2% to $67.0bn, net income fell 1.2% to $4.2bn.

Also filed around then

10 Jan 2025 — material impairment
13 May 2025 — departure or appointment of an officer or director
14 Feb 2025 — departure or appointment of an officer or director
13 Dec 2024 — departure or appointment of an officer or director

Net income fell in each of the last 3 fiscal years

By the numbersOver the same period: operating profit rose 65.0% to $15.1bn, revenue rose 8.6% to $61.2bn, tax rose to $2.4bn, interest rose 3.0% to $2.9bn.

Also filed around then

10 Jan 2025 — material impairment
13 May 2025 — departure or appointment of an officer or director
14 Feb 2025 — departure or appointment of an officer or director
13 Dec 2024 — departure or appointment of an officer or director

Cash from operations fell in each of the last 3 quarters

By the numbersOver the same period: net income rose 419.9% to $3.6bn, inventory rose 1.5% to $5.1bn, spending on property & equipment rose 21.5% to $322.0m.

Where this came from

Prices: licensed end-of-day data from Tiingo.
Figures: as filed with the SEC (XBRL facts), for the period ending 2026-06-30.
Calculated figures marked †: total debt combines filed long-term debt with current debt when reported separately; some quarters subtract the prior running total from the latest one.
Built 12 Sept 2026. Reports are rebuilt every night while readers are reading them.

Related comparison

Both depend on patented medicines and product pipelines; their therapy areas and patent timelines differ.

Open the ABBV and AMGN comparison

Four price measures are public. Financial rows require an account and use report access for both companies.